Transaction · 0001924980-26-000002
BIO BIO.BBIO-RAD LABORATORIES, INC.
Allison Schwartz
Allison Schwartz, DIR, reported a transaction classified as exercise at BIO-RAD LABORATORIES, INC. involving 42.000000 shares for an estimated $0.00. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
exerciseSEC transaction code MDIR
- Trade date
- Sep 01, 2026
- Filing date
- Sep 03, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
BIO BIO.B price since this filing
Daily closing prices, with the filing date and available return windowsBIO BIO.B · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001924980-26-000002 Restricted Stock Units
- Transaction date
- Sep 01, 2026 Filed Sep 03, 2026, 09:38 PM · 2d delay
- Shares
- 42 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 0 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership
Filing-only score
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
Mixed or weak signal
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
No officer title
Officer NoDirector Yes10% NoOther No
Footnotes & amended
- F1
Shares of Class A common stock acquired on the vesting of restricted stock units.
- F2
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F3
On September 1, 2022, the reporting person was granted 167 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
- F4
On September 1, 2023, the reporting person was granted 298 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Related transactions
Same SEC filing0 other transactions
Recent company activity
BIO BIO.B0 recent txs